In a significant boost to its fee-based services portfolio, Welcure Drugs & Pharmaceuticals Ltd has entered into a definitive sourcing and procurement mandate with Thailand-based Fortune Sagar Impex Company, valued at Rs. 517 crore. The agreement positions Welcure as a third-party procurement intermediary for multiple finished dosage SKUs and is structured around a 5% commission model. The transaction is expected to yield an estimated Rs. 25.85 crore in service income for FY 2025–26.